ciates, Bethesda, Md.); goat antiserum to human IgA, IgM, IgD, and IgE (Hyland Laboratories, Los Angeles, Calif.); and erythrocytes (RBC) from adult chickens. All sera were heat inactivated at 56 C for 30 min; acute and convalescent human sera, as well as goat antiserum to the various globulin fractions, were treated either with kaolin (13) , trypsin-periodate (12) , or receptor-destroying enzyme (8) .
HI tests were performed by the standard microtiter system (8) with rigid plastic microtitration plates containing 96 "V"-bottom wells. In a typical test, each well received 0.025 ml of diluent (phosphate-buffered saline, pH 7.2); test sera in 0.025-ml amounts were serially diluted in twofold steps. All serum dilutions then received 0.025 ml of four virus hemagglutinin units. After incubation at room temperature (22 to 24 C) for 1 hr, 0.025 ml of a 1:20 dilution of either goat antihuman IgG or normal goat serum was added to each well. After incubation at room temperature for 30 min, each well received 0.05 ml of 0.5% chick RBC suspension to give a total volume of 0.125 ml. Appropriate controls consisted of combinations of the different reagents with cells. Test patterns were read after incubation at room temperature for 1 to 2 hr. The HI titer was the reciprocal of the highest test serum dilution that completely inhibited hemagglutination.
Preliminary experiments revealed that the incorporation of anti-human IgG serum into the conventional HI test for influenza [reacting influenza A (PR8) or influenza B (Great Lakes) with homologous antiserum] increased the HI titer of human test sera 8-to 16-fold. Crossreactions between virus and heterologous antiserum did not occur in the presence of anti-IgG serum. Results of a determination on the optimal concentration of anti-IgG serum required to achieve maximal enhancement of test serum titers indicated that dilutions from 1:10 to 1:40 were most effective (Table 1) . A 1:20 dilution of antihuman IgG serum was routinely used in subsequent HI tests. In the presence of high concentrations of anti-IgG serum, a prozone of hemagglutination was noted. This occurred in all wells that received the 1:2 dilution of anti-IgG serum. The phenomenon could not be attributed to the presence of incomplete antibodies, because of the negative findings obtained by the antiglobulin test of Coombs (3) . As controls consisting of anti-IgG serum alone or in mixture with serum reagents failed to induce hemagglutination, the prozone of hemagglutination probably was related to the virus that may have been freed The capacity of goat antiserum to IgG of different animal species to enhance the HI titer of human serum was determined (Table 3) . Although maximal increases in titer were obtained with both anti-human and anti-monkey IgG sera, in general, the reactivity of anti-IgG serum in the test was species specific. The cross-reactivity between anti-monkey IgG and human test sera probably is the consequence of a common primate antigenic determinant. This has been encountered in anti-IgG serum neutralization tests with viruses (6) . When different classes of immunoglobulinsanti-IgA, anti-IgM, anti-IgD, or anti-IgE-were 
